Opportunity
SAM #75N98026Q00990
NIH Solicitation for PRISM Study of Compound NCGC01219867 in Cancer Cell Lines
Buyer
NIH Office of Logistics and Acquisition Operations
Posted
August 08, 2026
Respond By
August 24, 2026
Identifier
75N98026Q00990
NAICS
541715
The National Institutes of Health (NIH), Office of the Director, Office of Acquisitions, is seeking a contractor to conduct a PRISM study of the compound NCGC01219867. - Government Buyer: - National Institutes of Health (NIH), Office of the Director, Office of Logistics and Multiple Acquisition Operations - Services Requested: - PRISM study of compound NCGC01219867 - 5-day assay screening against approximately 900 barcoded cancer cell lines - Utilizes Luminex-format for high-throughput analysis - Data to be delivered to the NCATS PRISM Portal - Includes cell viability, assay quality metrics, feature set correlation analysis, and raw data - Contractor provides all services, personnel, materials, equipment, and facilities - Government supplies the compound analog - Unique/Notable Requirements: - Study must use the Broad Institute pooled cancer cell line drug sensitivity platform - Data delivery is required approximately 4 months after the submission window closes - No specific OEMs or commercial vendors are named in the solicitation - No product part numbers or hardware purchases are involved; this is a specialized research service
Description
(i) This is a combined synopsis/solicitation for commercial items prepared in accordance with FAR Subpart 12.6, as supplemented with additional information included in this notice. This announcement constitutes only solicitation; proposals are being requested, and a separate written solicitation will not be issued.(ii) The solicitation number is 75N98026Q00990. This solicitation is issued as a competitive combined synopsis/solicitation for commercial products or commercial services. The Government intends to award a contract or purchase order resulting from this solicitation using full and open competition.This acquisition is conducted under the authority of FAR 12.603, Streamlined Solicitation for Commercial Products or Commercial Services, and is not expected to exceed the simplified acquisition threshold (if applicable).The National Institutes of Health (NIH), Office of the Director, Office of Acquisitions, seeks to award a (Firm-Fixed-Price) to the offeror responsible whose proposal represents the best value to the Government.(iii) The solicitation document and incorporated provisions and clauses are those in effect through Federal Acquisition Circular effective August 7, 2026(iv) The associated NAICS code is 541715 Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology) and the small business size standard is 1000 employees.This requirement is unrestricted.